Cargando…
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial
SIMPLE SUMMARY: The treatment of advanced NSCLC patients unfit for a platinum combination is challenging and no clear evidence is available. We retrospectively collected data on advanced NSCLC not receiving a first-line platinum combination, focusing on clinical selection criteria. Up to 30% of newl...
Autores principales: | Camerini, Andrea, Del Conte, Alessandro, Pezzuto, Aldo, Scotti, Vieri, Facchinetti, Francesco, Ciccone, Lucia Pia, Perna, Marco, Sartori, Giulia, Puccetti, Cheti, Ricci, Alberto, Santo, Antonio, Tiseo, Marcello, Amoroso, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776592/ https://www.ncbi.nlm.nih.gov/pubmed/36551561 http://dx.doi.org/10.3390/cancers14246074 |
Ejemplares similares
-
Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
por: Camerini, Andrea, et al.
Publicado: (2015) -
The Unfit
por: Sinclair, W. J. H.
Publicado: (1911) -
The Unfit
Publicado: (1911) -
Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report
por: Valsuani, Chiara, et al.
Publicado: (2009) -
The Marriage of the Unfit
Publicado: (1898)